Nefazodone
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Synonyms / Brand Names: Nefazodona, Nefazodone Hcl, Nefazodone hydrochloride, Nefazodonum, Dutonin, Serzone
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Dosing and Administration
The recommended starting dose for Nefazodone hydrochloride tablets is 200 mg/day, administered in two divided doses (BID). In the controlled clinical trials establishing the antidepressant efficacy of Nefazodone, the effective dose range was generally 300 to 600 mg/day. Consequently, most patients, depending on tolerability and the need for further clinical effect, should have their dose increased. Dose increases should occur in increments of 100 mg/day to 200 mg/day, again on a BID schedule, at intervals of no less than 1 week. As with all antidepressants, several weeks on treatment may be required to obtain a full antidepressant response.
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Nefazodone
Return to top
Publication Resources
Most Recent Articles on Nefazodone
Review Articles on Nefazodone
Articles on Nefazodone in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Nefazodone
Return to top
Trial Resources
Ongoing Trials with Nefazodone at Clinical Trials.gov
Trial Results with Nefazodone
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Nefazodone
Cochrane Collaboration on Nefazodone
Cost Effectiveness of Nefazodone
Return to top
Media Resources
Powerpoint Slides on Nefazodone
Images of Nefazodone
Podcasts & MP3s on Nefazodone
Videos on Nefazodone
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Nefazodone
Discussion Groups on Nefazodone
Patient Handouts on Nefazodone
Blogs on Nefazodone
Nefazodone in the News
Nefazodone in the Marketplace
Return to top
International Resources
Nefazodone en Español
Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.

